Advertisement
U.S. Markets closed

Star Combo Pharma Limited (S66.AX)

ASX - ASX Delayed Price. Currency in AUD
0.12000.0000 (0.00%)
At close: 10:18AM AEDT
Currency in AUD

Valuation Measures4

Market Cap (intraday) 16.21M
Enterprise Value 12.88M
Trailing P/E 21.82
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.62
Price/Book (mrq)0.49
Enterprise Value/Revenue 0.65
Enterprise Value/EBITDA 6.08

Trading Information

Stock Price History

Beta (5Y Monthly) 0.44
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.1700
52 Week Low 30.1000
50-Day Moving Average 30.1453
200-Day Moving Average 30.1339

Share Statistics

Avg Vol (3 month) 314.74k
Avg Vol (10 day) 330.65k
Shares Outstanding 5135.08M
Implied Shares Outstanding 6N/A
Float 88.46M
% Held by Insiders 193.74%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 43.08%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 33.33%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Oct 14, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 2.87%
Operating Margin (ttm)4.04%

Management Effectiveness

Return on Assets (ttm)1.36%
Return on Equity (ttm)2.24%

Income Statement

Revenue (ttm)26.02M
Revenue Per Share (ttm)0.19
Quarterly Revenue Growth (yoy)4.60%
Gross Profit (ttm)N/A
EBITDA 1.73M
Net Income Avi to Common (ttm)747.33k
Diluted EPS (ttm)0.0100
Quarterly Earnings Growth (yoy)72.90%

Balance Sheet

Total Cash (mrq)7.36M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)4.03M
Total Debt/Equity (mrq)12.02
Current Ratio (mrq)3.77
Book Value Per Share (mrq)0.25

Cash Flow Statement

Operating Cash Flow (ttm)-316.45k
Levered Free Cash Flow (ttm)-1.76M